Home | All results_reference

[RDF data]
Results Reference #1106

Resource URI: http://static.linkedct.org/resource/results_reference/1106
linkedct:citation Mackay HJ, Hirte H, Covens A, et al.: A phase II trial of the histone deacetylase inhibitor belinostat (PXD101) in patients with platinum resistant epithelial ovarian tumors and micropapillary/borderline (LMP) ovarian tumors. A trial of the PMH phase II Consortium. [Abstract] American Association for Cancer Research: Molecular Targets and Cancer Therapeutics, October 22-26, 2007, San Francisco, CA A-160, 2007.
rdfs:label Results Reference #1106
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00301756>
linkedct:results_reference_id 1106 (xsd:int)
rdf:type linkedct:results_reference